Greenlight Biosciences Holdings Stock EBITDA
GreenLight Biosciences Holdings fundamentals help investors to digest information that contributes to GreenLight Biosciences' financial success or failures. It also enables traders to predict the movement of GreenLight Stock. The fundamental analysis module provides a way to measure GreenLight Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GreenLight Biosciences stock.
GreenLight |
GreenLight Biosciences Holdings Company EBITDA Analysis
GreenLight Biosciences' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current GreenLight Biosciences EBITDA | (153.99 M) |
Most of GreenLight Biosciences' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GreenLight Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, GreenLight Biosciences Holdings reported earnings before interest,tax, depreciation and amortization of (153.99 Million). This is 117.55% lower than that of the Biotechnology sector and 253.75% lower than that of the Health Care industry. The ebitda for all United States stocks is 103.95% higher than that of the company.
GreenLight EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GreenLight Biosciences' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GreenLight Biosciences could also be used in its relative valuation, which is a method of valuing GreenLight Biosciences by comparing valuation metrics of similar companies.GreenLight Biosciences is currently under evaluation in ebitda category among its peers.
GreenLight Fundamentals
| Number Of Shares Shorted | 4.79 K | |||
| Revenue | 6.38 M | |||
| EBITDA | (153.99 M) | |||
| Net Income | (167.06 M) | |||
| Cash And Equivalents | 34.75 M | |||
| Cash Per Share | 10.01 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 9.81 % | |||
| Book Value Per Share | (61.86) X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Number Of Employees | 280 | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
| Working Capital | 35.75 M | |||
| Z Score | -7.05 | |||
| Net Asset | 148.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in GreenLight Stock
If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |